TIY-7 is a selective and orally active tropomyosin receptor kinase ( TRK ) inhibitor. TIY-7 shows enzyme inhibitory activity with IC 50 s of 2.9, 1.1, 0.7, 0.8, 0.8, 0.2 nM for TRKA , TRKA G595R , TRKA G667C , TRKA F589L , TRKC G623R , TRKC G696A , respectively. TIY-7 shows anti-tumor potency in mouse xenograft model.
Products | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Trk Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.